| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 689133 | 1H,3H-Benzo[c]pyrrolo[3,4-a]carbazole-1,3-dione, 2,3a,3b,4,5,6,7,7a-octahydro-2-(4-methoxyphenyl)- 5-phenyl-9-(phenylmethoxy)- | 0.0163859626459254 | 0.16872665 |
| NSC 692655 | D-Homo-17a-aza-5-androsteno[17,16-c]pyrazol-3-yl,2'-(4-fluorophenyl)-, acetate | 0.0163859626459254 | 0.2373308 |
| NSC 694493 | 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(3-pyridinyl)- | 0.0163859626459254 | 0.2420764 |
| NSC 727719 | (-)-Leucascandrolide A | 0.0163859626459254 | 0.089570516 |
| NSC 735001 | Null | 0.0163859626459254 | 0.21310927 |
| NSC 743562 | Null | 0.0163859626459254 | 0.10329696 |
| NSC 747287 | Null | 0.0163859626459254 | 0.1990943 |
| NSC 756158 | GSK237700A | 0.0163859626459254 | 0.34247711 |
| NSC 80466 | 1H-Naphth[2,3-d]imidazolium, 4,9-dihydro-1,2-dimethyl-3-(2-methylpropyl)-4,9-dioxo-, iodide | 0.0163859626459254 | 0.32868832 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0171490505199911 | 0.41965696 |